Narayana Hrudayalaya Ltd
Fundamental Score
Narayana Hrudayalaya Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of NH across key market metrics for learning purposes.
Positive Indicators
11 factors identified
Strong Return on Equity (24.22%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (20.75%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Strong Operating Margins (20.32%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.
Robust Profit Growth (29.64%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Strong Revenue Growth (20.28%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Excellent EPS Growth (43.49% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (43.49% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Strong Interest Coverage (7.12x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Strong Cash Generation (₹1038.71 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (63.85%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
2 factors identified
Premium Valuation Risk (P/E: 45.92x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Financial Statements
Comprehensive financial data for Narayana Hrudayalaya Ltd
About NH
Business Overview
Narayana Hrudayalaya Limited provides medical and healthcare services in India and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood bank, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psychology, congenital adult heart disease, cosmetology, cranio-maxillofacial surgery, critical care medicine, dental, dermatology, pediatrics, diabetology, ENT, emergency medicine, endocrinology, family medicine, general and GI surgery, general medicine and surgery, geriatric medicine, gynecology, hematology, headache and facial pain management, transplant, infectious diseases, neurology, radiology, hepatobiliary surgery, gastroenterology, minimal access GI and bariatric surgery, neonatology, nephrology, neuro-otology, neuro-rehabilitation, neurosurgery and spine surgery, and nuclear medicine services. It also provides ophthalmology, orthopedics and joint replacement, pain management and palliative care, pathology, perinatology and fetal intervention, physical medicine and rehabilitation, physiotherapy and physical rehabilitation, plastic surgery, psychiatry, pulmonology, reproductive medicine, rheumatology, renal science, speech and swallow rehabilitation, spine surgery, thoracic and vascular surgery, ultrasonology, urology, and other services. In addition, the company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centers, and nursing homes. Further, it provides health insurance, consultancy services in the field of healthcare and hospitals, and IT services related to healthcare. Additionally, the company engages in investment activities; and develops software related to the healthcare industry. Narayana Hrudayalaya Limited was incorporated in 2000 and is headquartered in Bengaluru, India.
Company Details
Key Leadership
Corporate Events
Latest News
NH Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Narayana Hrudayalaya Ltd (NH)?
As of 29 Jan 2026, 10:35 am IST, Narayana Hrudayalaya Ltd (NH) is currently trading at ₹1742.20. The stock has a market capitalization of ₹39.05K (Cr).
Is NH share price Overvalued or Undervalued?
NH is currently trading at a P/E ratio of 45.92x, compared to the industry average of 52.84x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Narayana Hrudayalaya Ltd share price?
Key factors influencing NH's price include its quarterly earnings growth (Sales Growth: 20.28%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Narayana Hrudayalaya Ltd a good stock for long-term investment?
Narayana Hrudayalaya Ltd shows a 5-year Profit Growth of 43.49% and an ROE of 24.22%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.58 before investing.
How does Narayana Hrudayalaya Ltd compare with its industry peers?
Narayana Hrudayalaya Ltd competes with major peers in the Hospital. Investors should compare NH's P/E of 45.92x and ROE of 24.22% against the industry averages to determine its competitive standing.
What is the P/E ratio of NH and what does it mean?
NH has a P/E ratio of 45.92x compared to the industry average of 52.84x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹46 for every ₹1 of annual earnings.
How is NH performing according to Bull Run's analysis?
NH has a Bull Run fundamental score of 62.2/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does NH belong to?
NH operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting Narayana Hrudayalaya Ltd.
What is Return on Equity (ROE) and why is it important for NH?
NH has an ROE of 24.22%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently Narayana Hrudayalaya Ltd generates profits from shareholders' equity.
How is NH's debt-to-equity ratio and what does it indicate?
NH has a debt-to-equity ratio of 0.58, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.
What is NH's dividend yield and is it a good dividend stock?
NH offers a dividend yield of 0.24%, which means you receive ₹0.24 annual dividend for every ₹100 invested.
How has NH grown over the past 5 years?
NH has achieved 5-year growth rates of: Sales Growth 11.88%, Profit Growth 43.49%, and EPS Growth 43.49%.
What is the promoter holding in NH and why does it matter?
Promoters hold 63.85% of NH shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is NH's market capitalization category?
NH has a market capitalization of ₹39051 crores, placing it in the Large-cap category.
How volatile is NH stock?
NH has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for NH?
NH has a 52-week high of ₹N/A and low of ₹N/A.
What is NH's operating profit margin trend?
NH has a 5-year average Operating Profit Margin (OPM) of 20.32%, indicating the company's operational efficiency.
How is NH's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 20.28% and YoY Profit Growth of 29.64%.
What is the institutional holding pattern in NH?
NH has FII holding of 10.49% and DII holding of 7.76%. Significant institutional holding often suggests professional confidence in the stock.